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Liver disease is the major health issues in current era. Antioxidants play the essential role in hepatoprotection by 
protecting the hepatic cells against free radicals. Flavonoids and alkaloids are the essential plants bioactive that play the 
major role in the antioxidant system. In our project we used diamond flower Hedyotis corymbosa (L.) Lam. and Yellow 
berried Nightshade Solanum xanthocarpum Schrad & Wendl., and both plants have major phytoconstituent which acts as 
antioxidants. Thus, the aim of the current study validates the isolation, characterization, and determination of in vivo 
antioxidant and hepatoprotective consequences of corycavidine and quercetin that were isolated from Diamond flower 
Hedyotis corymbosa (L.) Lam. and Yellow berried Nightshade Solanum xanthocarpum Schrad & Wendl.. The study intent 
to isolate and identify the antioxidant and hepatoprotective agent from two different plants and compare their 
hepatoprotective potential to obtain the most effective liver protective phytoconstituent. Quercetin was isolated from 
S. xanthocarpum by column chromatography employing n-butanol: acetic acid: H2O (2:2:6) as a solvent system, however,
corycavidine was isolated from H. corymbosa by column chromatography employing chloroform: methanol: diethylamine
(4:1:2.2) as mobile phase. Structural illustrations were confirmed by UV, FT-IR, 1H-NMR, and 13C-NMR, and mass
spectroscopy. Both the phytoconstituents, corycavidine and quercetin, were explored for their antioxidant potential by
investigating CAT, SOD GSH, and LPO in liver homogenates of experimental rats. Additionally, the in vivo
hepatoprotective effect was examined against simvastatin (20 mg/kg, p.o.), which induced hepatotoxicity in experimental
rodents. The liver protective activity was computed by determining distinct biochemical parameters like SGOT, SGPT,
ALP, bilirubin, total protein, cholesterol and urea along with hematological parameters and histopathological studies. The
results of spectroscopic methods confirmed that the isolated phytochemical constituent from the H. corymbosa is
corycavidine, a benzylisoquinoline alkaloid, however from S. xanthocarpum is quercetin a flavonoid. Both
phytoconstituents significantly (P <0.05 P <0.001) and dose-dependently reversed simvastatin induced elevated levels of
SGOT, SGPT, cholesterol, urea, total bilirubin and restored the total protein and albumin level in experimental rats.
Furthermore, it also signifies the blood parameters at a dose of 50 and 100 mg/kg and restored the body protection system.
The histological examination exhibited that corycavidine and quercetin at a dose of 100 mg/kg showed regeneration of
hepatocytes around the central vein with nearly normal liver architecture. The results expressed the hepatoprotective
outcome of quercetin is preeminent than corycavidine and therefore, scientifically validates its traditional application.
Keywords: Corycavidine, Diamond flower, Flat-top millet grains, Kantakari, Liver disease, Oldenlandia corymbosa, 
Quercetin, Simvastatin,Wild Eggplant, Yellow berried Nightshade 
Liver damage, despite considerable advancement in 
medications, is a censorious health complication1,2. It 
is the vital organ and is accountable for generation of 
blood anticoagulant factors, synthesis and secretion of 
bile, and glycogenesis3,4. Globally, liver disease is the 
fifth fatal disease, including alcoholic liver disease, 
non-alcoholic fatty liver disease, hepatitis, liver 
cirrhosis, and hepatocellular carcinoma6-8. Many 
plants including algae and fungi are known to possess 
hepatoprotective potential9-14. Kadam et al.15 have 
demonstrated the protective effect of Solanum torvum 
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Solanum xanthocarpum Schrad & Wendl., 
commonly called Wild Eggplant or Yellow berried 
Nightshade, belongs to the genus Solanum L.,  
family Solanaceae. The plant contains steroidal 
alkaloids like solasodine, solamargine solanacarpine, 
solanacarpidine, carpesterol, diosgenin16. The  
fruits of S. xanthocarpum have been reported to 
contain steroidal alkaloids like solanacarpine, 
solanacarpidine, olanzapine, solasonine, kaempferol, 
and solamargine17. It also contains some coumarins 
aesculetin, aesculin, steroids campesterol, diosgenin 
campesterol, daucosterol, and triterpenes cycloartenol, 
and cycloartenol18. Chaudhury et al.6 have 
demonstrated anticancer and immunosuppressive 
potential of hot aqueous extract of whole plant. 
Hedyotis corymbosa (L.) Lam (Oldenlandia 
corymbosa), known as Diamond flower. Flat-top 
mille grains, is a flowering plant (Fam. Rubiaceae) 
and is broadly used in Chinese folk medicines for the 
treatment of cancer, bronchitis, throat infection, 
hepatitis, and eye infection. It is employed for treating 
venomous bites and exhibited anthelmintic, diuretic, 
expectorant, digestive, and stomachic properties19.  
H. corymbosa has various phytoconstituents like iridoid 
glucosides, anthraquinones, triterpenoids, alkaloids 
like protopine, corycavidine, p-coumaric acid, syringe 
acid, melilotic acid, p-hydroxybenzoic acid, ferulic 
acid, and caffeic acid20. Corycavidine is a benzo-
isoquinoline alkaloid present in different medicinal 
plants including H. coryambosa and C. meifolia21.  
In literature, there is no report available  on 
hepatoprotective activity of corycavidine. However, 
few reports are available on quercetin against  
ethanol induced liver toxicity22,23. Therefore, in the 
current study, we have made an attempt to isolate  
and characterize quercetin from the fruits of  
S. xanthocarpum and corycavidine from H. coryambosa 
and compare their hepatoprotective and antioxidant 
potential against simvastatin induced liver toxicity. 
 
Materials and Methods 
 
Plant collection and authentication 
The plant was collected from CSIR-National 
Botanical Research Institute, Lucknow, Uttar Pradesh, 
India, and authenticated by Dr. Alok Lehri, Principal 
Scientist, CSIR-NBRI.  
 
Isolation of phytoconstituent from H. corymbosa and  
S. xanthocarpum 
The bioactive compound was isolated from dried fruit 
material of S. xanthocarpum by column chromatography 
method. Ten grams of ethanolic fruit extract was 
chromatographed over packed stationary phase and then 
gradient elution was followed using solvents with 
increasing order of polarity. n-butanol: acetic acid: H2O 
(2:2:6) was used as a solvent system. To optimize the 
solvent system, initially the elution was started with 
100% n-butanol and then polarity was increased to get 
the pure form of quercetin using n-butanol:acetic acid 
(5:1), n-butanol:acetic acid (3:1), n-butanol:acetic acid 
(1:1), acetic acid (100%), acetic acid:H2O (5:1), acetic 
acid:H2O (3:1), acetic acid:H2O (1:1) and water. All the 
collected fractions were run for TLC with the same 
solvent system (n-butanol: acetic acid: H2O; 2:2:6) 
selected for the column. Based on the TLC profile, the 
Rf values of the fractions were calculated and compared 
with quercetin as standards. Finally, quercetin was 
characterized by UV-visible spectroscopy, Infrared 
spectroscopy (IR), 1H-NMR, 13C-NMR, and mass 
spectroscopy. Another bioactive compound 
corycavidine was isolated from H. corymbosa by 
column chromatography. As done earlier, 10 g of 
ethanolic extract was chromatographed over packed 
stationary phase, then gradient elution was followed 
using solvents with increasing order of polarity, 
chloroform: methanol: diethylamine (4:1:2.2) were used 
as solvent system. To optimize the solvent system 
initially the elution was started with 100% chloroform 
and then polarity was increased to get pure form of 
corycavidine using chloroform: methanol (5:1), 
chloroform:methanol (4:1), chloroform:methanol (3:1), 
chloroform:methanol (2:1), chloroform:methanol (1:1), 
methanol (100%), methanol:diethylamine (5:1), 
methanol:diethylamine(3:1), methanol:diethylamine(2:1), 
methanol:diethylamine(1:1) and diethylamine (100%). 
All the collected fractions were run for TLC with the 
same solvent system chloroform:methanol: diethylamine 
(4:1:2.2) selected for column. Based on the TLC profile, 
the Rf values of the fractions were calculated and 
compared with corycavidine as standard. Finally, 
corycavidine was characterized by UV-visible 




Wistar rats (150-180 g) and Swiss mice (25-30 g) 
of either sex were acquired from the animal house of 
Shri Ram Murti Smarak, College of Engineering and 
Technology, Bareilly, Uttar Pradesh, India. They were 
kept in the departmental animal house in the well 
cross-ventilated room at 22±2°C with light and dark 
cycles of 12 h for one week before and during the 
experiments. The experiment was carried out per the 




guidelines mentioned in the CPCSEA, and 
Institutional Animal Ethical Committee, India (Reg. 
No. 715/02/CPCSEA). 
 
Acute toxicity study of corycavidine and quercetin  
For oral acute toxicity study different groups of  
mice were charged with 50, 100, 300 and 500 mg/kg 
doses of quercetin and corycavidine as per OECD 




Wistar rats of either sex were divided into seven 
different groups, each group having 6 rats. Group I 
rats served as normal control, received distilled water 
only for 30 days. Group II rats were provided with 
simvastatin (20 mg/kg, p.o.) alone for 30 days orally. 
Group III & IV animals were treated with quercetin at 
50 and 100 mg/kg, and Group V & VI animals were 
treated with corycavidine at 50 and 100 mg/kg, p.o., 
respectively for 30 days. Group VII animals were also 
administered the same as Group II but treated with  
20 mg/kg, silymarin (Syl-20) p.o., for 30 days. On the 
31st day, blood samples were collected and all the 
animals were sacrificed by cervical dislocation under 
mild ether anesthesia and liver sample were 
harvested, rinsed in saline, and stored at 80°C for 
further biochemical and histological analysis.15 
 
Evaluation of liver protective activity 
The collected blood was allowed to clot and serum 
was separated by centrifugation in a refrigerated 
tabletop centrifuge at 2500 rpm for 15 min and the 
biochemical parameters like serum glutamic 
oxaloacetic transaminase (SGOT, U/L), serum 
glutamic-pyruvic transaminase (SGPT, U/L) alkaline 
phosphatase (ALP), total bilirubin (mg/dL), total 
protein, cholesterol (CHL, mg/dL) and urea (mg/dL) 
were evaluated24. 
 
Evaluation of antioxidant activity 
Antioxidant activity was examined in liver 
homogenate by investigating CAT, SOD25,26, GSH 
and LPO27,28. 
 
Evaluation of hematological parameters 
The fully automated hematology analyzer (XP 100 
Hematology Analyzer, Transasia Bio-Medicals Ltd., 
India) was used to determine red blood cell (RBC) 
count, hemoglobin (Hb), white blood cell (WBC) 
count, platelets (PLT) and lymphocytes. 
 
Histopathological examinations 
Histopathology was performed utilizing H&E 
stained sections of the liver at 40 and 100. All the 
slides were studied under the light microscope for any 




The statistical comparisons between the groups 
were made by one-way ANOVA, followed by 
Student-Newman-Keul’s test. The value P <0.05 was 
considered statistically using Graph Pad Prism 5.01 
Software. The values were represented as mean ± 
SEM for six rats.  
 
Results and Discussion 
 
Isolation of phytoconstituents 
Crude flavonoid (54 mg) was obtained from 6 kg 
powdered material of S. xanthocarpum fruit, the Rf 
value (0.32) of the isolated compound was the same 
as the standard quercetin that was confirmed by 
running standard quercetin as a parallel spot that has 
the same Rf. The melting point of the isolated 
compound was determined as 316-318°C, which was 
the same as standard quercetin30. Crude alkaloids  
(45 mg) were obtained from 6 kg powdered materials 
of H. corymbosa, the Rf value (0.32) of the isolated 
compound was found to be the same as that of the 
standard corycavidine which was confirmed by 
running standard corycavidine as a parallel spot on 
TLC. The melting point of the isolated compound was 
determined as 216-218°C, which was the same as 
standard corycavidine31. 
 
Characterization of the isolated compound 
UV confirmed the structure of the isolated 
compound, λmax was found to be 340.8 nm and IR 
(KBr, ν, cm-1): 3650 (O-H), 1656 (C-O), 1443 (C=C), 
1161 (aromatic ring stretching). 1H-NMR (300 MHz, 
CDCl3, δ, ppm): 2.493 (s, C7 hydroxyl group), 2.001 
(s, C5 hydroxyl group), 3.468 (s, C3 hydroxyl group), 
6.376-6.887 (m, aromatic ring), 7.519, 7.673, 9.358-
10.782 (m, aromatic ring), 4.652 (s, C3/ hydroxyl 
group). 13C-NMR (400 MHz, DMSO-d6, δ, ppm): 
136.17 (C-8), 147.27 (C-6), 176.29 (C-4), 93.84 (C-5), 
98.65 (C-7), 103.46 (C-3/), 122.41 (C-4/), 120.48 (C-3). 
Mass spectrum of the compound showed parent 
molecular ion [M+] peak at m/z 303.2, which 
corresponds to the molecular formula C15H10O7. This 
assessment is overall in good agreement with the 
structure of quercetin20. 
UV confirmed the structure of isolated compound, 
λmax was found to be 276.20 nm and IR (KBr, ν, cm
-1): 
2917 cm-1 [CH3(C-H) Asym/Sym Stretch)], 1441.9 cm-1 
[(C=C-) Aromatic Ring Stretching)], 1738 cm-1 




(C=O) and 1099 cm-1 (C-N).1H-NMR (300 MHz, 
CDCl3, δ, ppm): 1.15 (s, C11), 2.71 (s, OCH3), 2.77-
3.11 (m, aromatic ring), 6.13-6.20 (m, aromatic 
ring).13C-NMR (400 MHz, DMSO-d6, δ, ppm): 
122.41(C-14), 176.29 (C-2), 120.48 (C-5), 122.41 (C-6), 
93.84 (O-CH3), 98.65 (O-CH3), 116.05 (C-11), 111.3 
(C-4), 112.1 (C-11), 126.2 (C-12), and 103.46  
(O-CH2-O). Mass spectrum of compound showed 
parent molecular ion [M+] peak at m/z 383.4, which 
corresponds to the molecular formula C22H25NO5. 
This assessment is overall in good agreement for the 
structure of corycavidine.  
 
Acute oral toxicological outcome 
The isolated quercetin and corycavidine did not 
show any symptom of mortality up to a dose of  
500 mg/kg p.o. for 7 days in mice.  
 
Effect of quercetin and corycavidine on serum hepatic 
parameters 
In human beings, liver ailments are one of the 
predominant and considerate health system defects 
worldwide, which are usually credited to viruses, 
alcohol, and different chemicals. The quest to 
understand a hepatoprotective agent has to turn out to 
be a key challenge over the past decades32. Some 
indispensable and nonessential elements from plant 
origin also have sturdy antioxidant undertaking33. 
Most of the hepatotoxic agents produced free radicals 
and induce oxidative stress, which acts on hepatic 
parenchyma cells34. These parenchyma cells are the 
sites for the production of various liver enzymes. 
Protection in hepatic parenchymal cells by toxins is 
the major functions of the liver. For this reason, 
antioxidant enzymes represent the first line of defense 
in opposition to oxidative stress and harm triggered 
by way of free radicals35. Likewise, simvastatin 
increases the level of hepatic markers4, like GOT, 
GPT, ALP, total bilirubin, cholesterol and urea, while 
diminished the serum total protein level, which 
resulted in the dysfunction of the liver36,37. Injury of 
hepatocytes and obstruction in excretory ducts of the 
liver interferes with the capability of the liver to 
excrete normal levels of bilirubin. Thus, serum 
bilirubin is generally used to identify proper liver 
functioning. Total bilirubin is a combination of 
nonhepatic (indirect) bilirubin and hepatic (direct) 
bilirubin38. ALP is considered a leading maker of 
hepatobiliary effects and cholestasis39. Administration 
of quercetin and corycavidine in the study suppressed 
the increased hepatic serum marker enzymes like 
GOT, GPT, cholesterol, urea, and complete bilirubin 
while elevated the complete protein and albumin 
levels in a dose-dependent manner40. However, 
quercetin exhibits more hepatoprotective effect as 
compare to corycavidine as per hepatic serum markers 
are concerned.  
Simvastatin (20 mg/kg, p.o.), treated rodents 
demonstrated the noteworthy inclination of liver 
serum markers like SGOT, SGPT, CHL, bilirubin 
(BLB), urea level while declination in the TP and 
ALB levels. The rodents administered with 50 and 
100 mg of quercetin demonstrated altogether 
declination in the SGOT, SGPT, CHL, bilirubin 
(BLB), urea levels while augmenting TP and ALB in 
subordinate way. Hepatic damage instigated by 
simvastatin caused significant changes in marker as 
SGOT by 141.45%, SGPT by 92.08%, CHL by 
117.09%, urea by 49.66%, ALB by 32.5%, BLB by 
201.7 and protein by 73.11% compared with control. 
The % defence in marker of treated rodents at  
50 mg/kg of quercetin for SGOT was 24.27 (P <0.001), 
SGPT 20.50 (P <0.01), CHL 28.52 (P <0.001), urea 
20.58 (P <0.001), ALB 18.93 (P <0.001), BLB 49.11 
(P <0.001) and protein 676.85 (P <0.001) compared 
with simvastatin 20 mg/kg, charged rodents while 
greatest % defence was observed at 100 mg/kg of 
quercetin and silymarin (20 mg/kg) as SGOT 37.49  
(P <0.05), 45.16 (P <0.001), SGPT 36.55 (P <0.001), 
46.41 (P <0.001), CHL 39.35 (P <0.001), 41.88  
(P <0.001), urea 29.26 (P <0.001), 31.61 (P <0.001), 
ALB 32.09 (P <0.001), 44.03 (P <0.001), BLB 62.72 
(P <0.001), 46.15 (P <0.001) and protein 503.30  
(P <0.05), 185.12 (P <0.001) which is practically 
equivalent to the group treated with silymarin, an 
intense liver defensive medication utilized as 
reference standard. The % defence in marker of 
treated rodents at 50 mg/kg of corycavidine for SGOT 
was 11.41 (P <0.01), SGPT 8.84 (P <0.01), CHL 5.63 
(P <0.001), urea 14.57 (P <0.001), ALB 5.34  
(P <0.01), BLB 33.13 (P <0.01) and protein 88.42  
(P <0.01) compared with simvastatin 20 mg/kg, 
charged rodents while greatest % defence was 
observed at 100 mg/kg of corycavidine and silymarin 
(20 mg/kg) as SGOT 21.38 (P <0.001), 45.16  
(P <0.001), SGPT 26.65 (P <0.001), 46.41 (P <0.001), 
CHL 16.09 (P <0.001), 41.88 (P <0.001), urea 21.41 
(P <0.001), 31.61 (P <0.001), ALB 25.10 (P <0.001), 
44.03 (P <0.001), BLB 47.33 (P <0.001), 46.15  
(P <0.001) and protein 173.55 (P <0.001), 185.12  
(P <0.001) which is practically equivalent to the group 
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treated with silymarin, an intense liver defensive 
medication utilized as reference standard. The results 
are presented in Table 1. 
Effect of quercetin and corycavidine on in-vivo antioxidant 
tests against simvastatin induced liver toxicity 
Although both exhibit excellent hepatoprotective 
properties and have some role in preserving the 
structural integrity of the hepatocellular membrane, 
thus preventing enzyme leakage into the blood 
circulation41, as well as repairing hepatic tissue damage 
caused by Simvastatin. This effect is in agreement with 
the commonly accepted view that serum levels of 
transaminases return to normal with the healing of 
hepatic parenchyma as well as decreased the severity 
of hepatic fibrosis and the regeneration of 
hepatocytes42. The results indicated that the treatment 
of experimental rodents with quercetin and 
corycavidine cause a significant decrease in the levels 
of LPO in liver homogenate, which indicates their 
liver-protective efficacy43. Quercetin restored the 
activity of GSH, CAT, and SOD, and avoiding lipid 
peroxidation in a more prominent way as compare to 
corycavidine44. Although both delay or inhibit 
oxidative damage to target molecules, therefore 
intracellular and extracellular antioxidants protect the 
tissues from this oxidative damage.  
 
The outcomes in Fig 1, presented clear noteworthy 
changes in the dimensions of LPO in simvastatin 
20 mg/kg, inebriated rodents as 121.31 (P <0.001) 
compared with control. Treatment with quercetin as 
well as corycavidine at the doses of 50 and 100 mg/kg 
essentially kept this hurl in levels and the rate 
insurance in LPO was 240.93 (P <0.001) and 46.97 
(P <0.001) individually for quercetin, however the 
rate insurance for corycavidine at the dose level of 50 
and 100mg/kg, in LPO was 18.13 (P <0.01) and 35.16 
(P <0.001) individually. The GSH, SOD, and CAT 
content had fundamentally expanded in quercetin-
treated groups, however simvastatin 20 mg/kg, 
inebriated groups had demonstrated huge abatement 
in these parameters contrasted with the control group. 
The % change of GSH, SOD, and CAT in SIM-20 
inebriated gathering were as 58.51 (P <0.001), 63.66 
(P <0.001), and 54.15 (P <0.001) individually. The 
rate insurance in GSH as 61.53 (P <0.001), 102.56 
(P <0.001) and SOD 80.22 (P <0.001), 132.23 
(P <0.001) while in CAT 44.43 (P <0.001), 92.40 
(P <0.001) at the portions dimensions of 50 mg/kg 
and 100 mg/kg of quercetin dose, individually. 
Nevertheless, quercetin at 100 mg/kg has 
demonstrated the most extreme security that was 
practically equivalent to those of the ordinary control 
and silymarin. The rate insurance in GSH as 25.64 
(P <0.01), 74.35 (P <0.001) and SOD 22.63 
(P <0.01), 95.41 (P <0.001) while in CAT 16.29 
(P <0.01), 67.35 (P <0.001) at the portions 
Table 1 — Effect of quercetin and corycavidine on serum enzymes and biochemical indices against Simvastatin induced liver toxicity in rats 
Treatment SGOT (U/L) SGPT (U/L) BLB (mg/dL) TP (mg/dL) ALB (mg/dL) CHL (mg/dL) Urea (mg/dL) 
Control (Gr. I) 32.4±1.2 22.6±1.2 0.56±0.01 4.5±0.02 3.6±0.01 98.21±3.2 5.96±0.2 
Sim-20 (Gr. II) 78.23±2.1† 43.41±1.5† 1.69±0.03† 1.21±0.01† 2.43±0.02† 213.21±4.3† 8.92±0.5† 
Q-50 (Gr. III) 59.24±4.5** 34.51±3.1*** 0.86±0.03*** 9.4±0.04*** 2.89±0.01*** 152.4±2.2*** 7.06±0.5*** 
Q-100 (Gr. IV) 48.9±3.2*** 27.54±1.5*** 0.63±0.02*** 7.3±0.05*** 3.21±0.02*** 129.3±3.1*** 6.31±0.4*** 
C-50 (Gr. V) 69.3±2.9** 39.57±1.9** 1.13±0.03** 2.28±0.02** 2.56±0.03** 201.2±3.4*** 7.62±0.3*** 
C-100 (Gr. VI) 61.5±3.1*** 31.84±1.6*** 0.89±0.05*** 3.31±0.03*** 3.04±0.02*** 178.9±2.9*** 7.01±0.4*** 
Syl-20 (Gr. VII) 42.9±2.7*** 23.25±2.2*** 0.58±0.02*** 3.43±0.07*** 3.5 ±0.02*** 123.9±2.5*** 6.1  ±0.2*** 
[Values are mean ± SEM. of 6 rats in each group, n: non-significant. P values:  †<0.001 compared with respective control group (Gr. I); 
P values: * <0.05, **<0.01, ***<0.001 compared with Gr. II] 
Fig. 1 — Effect of pretreatment with quercetin (50 and 100 mg/kg, body wt.) and corycavidine (50 and 100 mg/kg, body wt.) on In vivo 
antioxidant enzymes [(A) GSH; (B) LPO; (C) SOD; & (D) CAT] against Simvastatin induced liver toxicity. [values are mean ± SEM of 
6 rats in each group, n: non-significant. P values:  †<0.001 compared with the respective control group (Gr. I). P values: * <0.05, **<0.01, 
***<0.001 compared with Gr. II]. 




dimensions of 50 mg/kg and 100 mg/kg of 
corycavidine dose, individually. Nevertheless, 
quercetin  at  100 mg/kg  has  demonstrated  the  most 
extreme security that was practically equivalent to 
those of the ordinary control and silymarin. 
Corycavidine at 100 mg/kg has demonstrated a 
greater antioxidant effect as compared to 50 mg/kg of 
corycavidine that was practically confirmed.  
 
Effects of quercetin and corycavidine on the hematological 
parameters in rats 
Erythrocytes and hemoglobin exhibit the principal 
function in the transportation of oxygen and carbon 
dioxide45. Inside the RBCs iron is present, which 
facilitates oxygen transportation to the tissues or 
cells46. Quercetin upsurge the level in the RBCs, 
while at low dose its non-significant accelerated 
hemoglobin levels as compared to control, for this 
reason, these might be indicated in anaemia. 
Quercetin stimulates the kidney to release the 
erythropoietin hormone which in turn stimulates the 
pluripotent stem cell of red bone marrow for 
erythropoiesis47,48. Thrombocytopenia is the most 
splendid hemostatic imperfection for bleeding in 
dengue infection49. Quercetin and corycavidine 
notably elevated the platelets count and it may 
additionally be due to stimulation of thrombopoietin 
hormone, and has the hemostatic aptitude50, 
consequently for this reason quercetin51 in comparison 
to corycavidine can be used as a drug of choice for the 
remedy of dengue fever as well. Leucocytes provide 
indications on the number of infections of visceral 
organs. Augmentation of leucocytes arousing the 
immune system, in retort to noxious environment52. 
Lymphocytes and monocytes are the principal cells of 
the RES (reticuloendothelial system)53 and its level 
increased swiftly with the aid of the pathogenic 
assault and performs the chief function in body 
defense mechanisms54,55. Increased WBCs and 
Lymphocytes levels due to quercetin and 
corycavidine administration might instigate the 
immune system of the animals. Quercetin and 
corycavidine at different dose levels offer liver 
protection, in a dose-dependent manner. It supports 
our finding s that quercetin protects liver better than 
corycavidine in simvastatin-induced liver toxicity. 
Table 2, emphasizes the significant changes in RBCs, 
Hb, PLT, WBCs, and % lymphocytes count. 
Simvastatin produced significant changes in blood 
parameters as RBCs by 31.71%, Hb by 24.59%, PLT 
by3.23%, and % lymphocytes by 10.74% were 
declined as compared to the control group. The 
animals which were treated with 50 and 100 mg/kg of 
quercetin showed the % increment in RBCs by 49.90 
and 65.06%; Hb by 46.73 and 56.52%; PLT by 5.17 
and 7.38% while decrease in WBCs by 49.4 and 
46.01%; and % lymphocytes by 26.64  and 21.20% as 
compared to simvastatin treated animals. However, 
animals which were treated with 50 and 100 mg/kg of 
corycavidine showed the % increment in RBCs by 
20.53 and 53.16%; Hb by 15.21 and 37.82%; PLT by 
0.43 and 2.5% while decrease in WBCs by 4.07 and 
24.61%; and % lymphocytes by 7.62 and 14.06% as 
compared to simvastatin treated animals.  
 
Effects of quercetin and corycavidine on body weight and 
liver weight against simvastatin induced liver toxicity 
Furthermore, the liver protective activity of 
quercetin is quite similar to silymarin, as a reference 
hepatoprotective agent. Changes in organ weight are 
considered as a sensitive indicator that assesses the 
toxic effects between treated and untreated groups of 
animals56,57. The body weight and the liver weight 
differed appreciably between the Sim-20 treated 
group and the normal control group. However, 
therapy with quercetin and corycavidine has 
diminished the impact of Sim-20 on a rat body weight 
and liver weight. The results of our findings reveal the 
significant preventive effect on liver toxicity against 
simvastatin.  
In the toxic group (Sim-20), the body weight was 
decreased by 4.43% while liver weight was 
Table 2 — Effect of quercetin and corycavidine on the hematological parameters against Simvastatin induced liver toxicity in rat 
Treatment RBC (×1012) Hb (g/dL) PLT (×109/L) WBC (×109) Lymphocytes (%) 
Control (Gr. I) 7.6±0.1 13.01±0.2 613.2±5.6 8.1±0.12 41.2±2.1 
Sim-20 (Gr. II) 5.21±0.3† 9.2±0.4† 598.6±2.6† 5.89±0.4† 34.9±1.9† 
Q-50 (Gr. III) 7.81±0.3** 13.5±0.4** 629.6±4.1*** 8.8±0.5*** 44.2±3.1*** 
Q-100 (Gr. IV) 8.6±0.2*** 14.4±0.3*** 642.8±4.2*** 8.6±0.2*** 42.3±3.2*** 
C-50 (Gr. V) 6.28±0.1** 10.6±0.2** 601.2±5.2* 6.13±0.4* 37.56±3.8** 
C-100 (Gr. VI) 7.98±0.2*** 12.68±0.3*** 613.6±4.2*** 7.34±0.2*** 39.81±3.2*** 
Syl-20 (Gr. VII) 9.26±0.2*** 14.2±0.3*** 614.5±4.2*** 8.4±0.2*** 42.58±3.2*** 
[Values are mean ± SEM. of 6 rats in each group, n: non-significant. P values:  †<0.001 compared with respective control group (Gr. I);
P values: * <0.05, **<0.01, ***<0.001 compared with Gr. II] 




increased by 33.55%. The animal treated with  
50 mg/kg of quercetin significantly increased their 
body weight by 0.86%, whereas the liver weight was 
decreased by 15.3%. The animal treated with  
100 mg/kg of quercetin, significantly increased their 
body weight by 2.48%, while liver weight was 
decreased by 25.59%. The animal treated with  
50 mg/kg of corycavidine significantly increased 
their body weight by 0.0.672%, whereas the liver 
weight was decreased by 5.80%. The animal treated 
with 100 mg/kg of corycavidine, significantly 
increased their body weight by 1.14%, while liver 
weight was decreased by 20.31%. The results are 
represented in Fig. 2.  
 
Histopathological observations 
The hepatic section of normal control (Gr. I) rats in 
Fig. 3, showed normal hepatic cells with youthful 
cytoplasm. In the negative control group i.e. simvastatin 
(20 mg/kg) treated rats (Gr. II), displayed the macro-
vesicular and micro vesicular steatosis, cholestasis 
(Indicated by arrow 4, 5, 2), hypereosinophilic 
cytoplasm (Indicated by arrow 6), the appearance of 
ballooning cells with Mallory and councilman bodies 
(Indicated by arrow 1), lobular injury and bile plug seen 
in canalicular spaces (Indicated by arrow 3), whereas, 
animal treated with 50 mg/kg of quercetin (Gr. III) 
showed with less central vein congestion with less 
cholestasis with absent of steatosis. The animal treated 
with 100 mg/kg of quercetin (Gr. IV), showed the 
absence of Mallory and councilman bodies in the 
balloon with the revival of hepatocytes and owning 
supreme hepatoprotection. The animal treated with  
50 mg/kg of corycavidine (Gr. V), showed moderate 
Mallory bodies, loss of hepatic membrane with 
moderate congestion in the central vein however rodents  
dosed with 100 mg/kg of corycavidine (Gr. VI), showed 
 
 
Fig. 3 — Hepatic section of (A) normal control (Gr. I) showing normal hepatic cells with youthful cytoplasm H & E 40X; (B) negative
control group i.e. Simvastatin (20 mg/kg) treated rats (Gr. II) displaying the macro-vesicular and micro-vesicular steatosis, cholestasis 
(Indicated by arrow 4, 5, 2), hypereosinophilic cytoplasm (Indicated by arrow 6), the appearance of ballooning cells with Mallory and 
councilman bodies (Indicated by arrow 1), lobular injury and bile plug seen in canalicular spaces (Indicated by arrow 3) H & E 100X; 
(C) Gr. III, rats treated with 50 mg/kg of quercetin H & E 100X; (D) Gr. IV, rats treated with a large dose of quercetin (100 mg/kg)
H & E 40X; (E) Gr. V, rats treated with a low dose of corycavidine (50 mg/kg) H & E 40X; (F) Gr. VI, rats treated with the higher dose 
of corycavidine (100 mg/kg) H & E 40X; and (G) Gr. VII, rats treated with standard treatment silymarin (20 mg/kg) exhibited
well-preserved cytoplasm, with near-normal architecture H & E 40X. 
 
 
Fig. 2 — Effects of quercetin (50 and 100 mg/kg, body wt.) and 
corycavidine (50 and 100 mg/kg, body wt.) on body weight 
and liver weight against simvastatin induced liver toxicity. [values are 
mean ± SEM of 6 rats in each group, n: non-significant. 
P values:  †<0.001 compared with the respective control group (Gr. I).
P values: * <0.05, **<0.01, ***<0.001 compared with Gr. II]. 




the absence of moderate Mallory bodies, regeneration of 
hepatic membrane with a repaired central vein. The rats 
treated with Sim-20 (Gr. VI) exhibited well-preserved 
cytoplasm, with near-normal architecture.  
 
Conclusion  
As per the clinical significance of the test drug is 
concerned, it can be correlated with its exclusive 
indication with antihyperlipidemic drugs as 
prophylaxis to prevent liver toxicity. The above 
results suggest that quercetin might be a better drug of 
choice as prophylaxis to prevent hepatotoxicity 
induced by simvastatin as compared to corycavidine. 
Both phytoconstituents, quercetin and corycavidine, 
showed significant antioxidant and liver protection, 
and quercetin offers better hepatic defensive action as 
compared to corycavidine against simvastatin induced 
liver toxicity in rats.  
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